Identification of HO-1 as a novel biomarker for graft acute cellular rejection and prognosis prediction after liver transplantation

BACKGROUND: Liver transplantation (LT) is the most effective treatment for patients with end-stage liver diseases, but acute rejection is still a major concern. However, the mechanisms underlying rejection remain unclear. Biomarkers are lacking for predicting rejection and long-term survival after L...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Junjun, Nie, Yu, Geng, Lei, Li, Jianhui, Liu, Jimin, Peng, Yifan, Huang, Junjie, Xie, Haiyang, Zhou, Lin, Zheng, Shu-Sen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154463/
https://www.ncbi.nlm.nih.gov/pubmed/32309368
http://dx.doi.org/10.21037/atm.2020.01.59

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154463/
https://www.ncbi.nlm.nih.gov/pubmed/32309368
http://dx.doi.org/10.21037/atm.2020.01.59

Ejemplares similares